language English
Meeting Abstract 2021 · 0 atıf

Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

Ozbalak, Murat, Akay, Olga Meltem, Pehlivan, Mustafa, Yildiz, Birol, Uzay, Ant, Yigenoglu, Tugce Nur, Elverdi, Tugrul, Kaynar, Leylagul, Ayyildiz, Orhan, Hindilerden, Ipek Yonal, Goksoy, Hasan Sami, Guner, Sebnem Izmir, Gunes, Ahmet Kursad, Sonmez, Mehmet, Yuksel, Meltem Kurt, Bozdag, Sinem Civriz, Ozkurt, Zubeyde Nur, Toptas, Tayfur, Dogu, Mehmet Hilmi, Salim, Ozan, Saydam, Guray, Yavasoglu, Irfan, Ayli, Meltem, Ozet, Gulsum, Albayrak, Murat, Atesoglu, Elif Birtas, Toprak, Selami K., Yildirim, Rahsan, Mehtap, Ozgur, Besisik, Sevgi Kalayoglu, Nalcaci, Meliha, Altuntas, Fevzi, Ferhanoglu, Burhan

Özet

Bu yayın için özet verisi bulunmuyor.

Anahtar Kelimeler
relapsed and refractory Hodgkin lymphoma brentuximab vedotin autologous stem cell transplantation consolidation
WoS Kategorileri
Oncology Hematology
Künye
Dergi
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Yıl
2021
Cilt
21
Sayfa
S368-S369
ISSN
2152-2650
eISSN
2152-2669
WoS UID
WOS:000691910500283